What is included in this presentation?

Tesamorelin + Ipamorelin + CJC No DAC 12mg Blend is supplied as lyophilized peptide blend with a listed amount of 12mg total (6mg + 3mg + 3mg).

What does the physical form mean?

Lyophilized means the material has been freeze-dried into a dry form. Any prepared-solution conditions should be established under the laboratory’s validated procedure.

How is laboratory documentation presented?

Available laboratory records can be reviewed in the MyPurePeptide Lab Tests directory. This page does not claim a current task-matched report when one is not mapped.

What is the primary laboratory study system?

The page is organized around ghrh-receptor, secretagogue-receptor, peptide-identity, and analytical systems. Exact controls, concentrations, and acceptance criteria belong in the laboratory protocol.

Where are orders fulfilled?

MyPurePeptide fulfills orders from Austin, Texas, USA.

How quickly do in-stock orders ship?

Most in-stock orders placed before 1:00 PM CT ship the same business day after order review and payment approval.

How should the material be stored?

Keep unopened material sealed, dry, protected from light, and under the conditions stated on the label or available lot documentation. After reconstitution depends on solvent, concentration, container, and protocol.

Is this material intended for human or veterinary use?

No. It is supplied for laboratory research use only and is not intended for human or veterinary use.

MyPurePeptide

Trusted Purity

Tesamorelin + Ipamorelin + CJC No DAC 12mg Blend

$35.00

Research profileLab documentation

Three-component research blend containing tesamorelin, ipamorelin, and CJC No DAC for component-resolved receptor, peptide-identity, and analytical studies.

MaterialTesamorelin / Ipamorelin / CJC-1295 No DAC Blend 12 mg

Amount12mg total (6mg + 3mg + 3mg)

FormLyophilized peptide blend

DocumentationView available lab records

FulfillmentAustin, Texas, USA

Storage (dry)Sealed, dry, protected from light; follow the product label and available lot documentation.

Short descriptionThree-component research blend containing tesamorelin, ipamorelin, and CJC No DAC for component-resolved receptor, peptide-identity, and analytical studies.

U.S. + international shippingRates shown at checkout 7-day returnsEligible unopened products Customer supportMonday–Saturday, 9:00 AM–7:00 PM CT

In stock · Fulfilled from Austin, TexasMost in-stock orders are usually processed within 1 business day after order review and payment approval.

Category: Research Materials

Tags: new

Compound Details

RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

IdentityTesamorelin + Ipamorelin + CJC No DAC

ClassificationThree-component GHRH/secretagogue research blend

Primary study systemGHRH-receptor, secretagogue-receptor, peptide-identity, and analytical systems

Presentation12mg total (6mg + 3mg + 3mg)

Physical formLyophilized peptide blend

Research designationTesamorelin 6mg + Ipamorelin 3mg + CJC No DAC 3mg

Current lot documentation

Vial & third-party laboratory report

Review the vial/sample image and laboratory report,
then open the published laboratory verification record.

Verify on Janoshik

Current third-party laboratory report — Laboratory report

The laboratory verification record is the controlling
source for lot-specific analytical information.

Unopened-material storageKeep unopened material sealed, dry, protected from light, and under the conditions stated on the product label or available lot documentation.

This presentation combines tesamorelin 6mg, ipamorelin 3mg, and CJC No DAC 3mg in one lyophilized research vial.

Tesamorelin and CJC-type peptides are studied in relation to the GHRH receptor system, while ipamorelin is a distinct secretagogue peptide; component-resolved controls are therefore important when interpreting a blend.

ClassThree-component GHRH/secretagogue research blend

Primary study systemGHRH-receptor, secretagogue-receptor, peptide-identity, and analytical systems

Supplied amount12mg total (6mg + 3mg + 3mg)

FormLyophilized peptide blend

GHRH receptor system

GHRH analogs can be studied with receptor-binding, structural, and downstream signaling assays centered on GHRHR.

Ipamorelin chemistry

Ipamorelin is a pentapeptide secretagogue that can be characterized separately in receptor and structure-activity systems.

Component-resolved analysis

Mass-spectrometric methods can distinguish peptide components, parent compounds, and related species.

Blend controls

Single-component controls help separate each peptide’s assay behavior from any combined readout.

GHRHR studies

Measure ligand recognition or signaling in defined GHRH-receptor systems.
Component identity

Use LC-MS or other orthogonal methods to confirm each blend component.
Structure–activity comparison

Compare GHRH-family analogs or secretagogue peptides under matched assay conditions.
Blend stability

Track component-specific stability and degradation under validated laboratory conditions.

Method note: Controls, concentrations, matrices, acceptance criteria, and storage conditions belong in the laboratory’s validated protocol. Interpret results within the specific assay system used.

References are provided for compound identity, chemistry, receptor/assay context, or analytical methods. A cited paper does not establish a claim for this commercial research material.

Research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

Your cart (items: 0)

Products in cart
Product	Details	Total
	Available on backorder Previous price: Discounted price:	Save

Available for research and laboratory purposes only. Please review our Terms and Conditions before ordering.